Here are eight things for spinal surgeons to know for March 30, 2017.
FDA clears 1st cervical cage for use in 4 contiguous levels
San Diego-based NuVasive announced FDA clearance of its CoRoent Small Interbody System for up to four contiguous levels. The FDA cleared the CoRoent Small Interbody System for intervertebral body fusion at multiple adjacent levels in the cervical spine, marking the first time a cervical cage has been cleared for use in up to four contiguous levels.
Spinal fusion physician fees for the largest US cities in 2010 — Charlotte, NC tops the list at $9.9k
Of the 30 largest cities in the United States, San Jose, Calif., is the most expensive place to receive cervical spine surgery, according to Healthcare Blue Book. However, the physician services fees are highest in Charlotte, N.C., for cervical spinal fusions, hitting $9,903. Check out the breakdown for average physician services fees for the 30 largest U.S. cities, based on the 2010 census, here.
Implanet reports 18% jump in 2016 revenue
Implanet's revenue jumped last year, driven by the U.S. market growth. The company's 2016 revenue grew 18 percent over 2015, owing in large part to the 46 percent growth in spine revenue. The company reported 2016 sales grew 70 percent in the United States and 33 percent in France. The company plans to grow its JAZZ technology platform. There are currently 127 surgeons across France and the United States using the technology, which has regulatory approval in both countries.
InVivo's Inspire study: 7th patient reports improvement after spinal cord injury treatment
InVivo Therapeutics enrolled another patient in its INSPIRE study of the Neuro-Spinal Scaffold for spinal cord injury patients. The most recent patient is the seventh out of 11 patients who reported an AIS grade improvement at the one-month follow-up after the procedure. The trial's conversion rate is currently 63.6 percent. The patient improved from AIS A to AIS B spinal cord injury between the one- and two-month evaluations.
Dr. James Lynch first Nevada surgeon to use Titan Spine technology
James Lynch, MD, of Reno-based SpineNevada, was the first surgeon in the state to use Titan Spine's nano surface technology in anterior lumbar interbody fusion and lateral lumbar interbody fusion procedures. The Titan Spine's implant surface technology promotes differentiation into bone-forming cells, increasing bone production around the implant site and expediting the fusion process. Dr. Lynch performs spine surgeries in hospital and outpatient center settings throughout Nevada.
Remedy Partners reports 7.7% episode of care savings through voluntary bundled payment models
Darien, Conn.-based Remedy Partners reported 7.7 percent savings achieved under Medicare's Bundled Payments for Care Improvement initiative. Remedy predicts saving the Medicare Trust Fund approximately $120 million at a 7.7 percent savings rate in 2017. In addition to the cost savings, Remedy has reduced hospital readmissions by 11.48 percent in hospitals and 11.19 percent in skilled nursing facilities for quarter one fiscal year 2016.
Global MIS spine market to grow at nearly 7.6% CAGR through 2020
The global minimally invasive spine surgery is set to grow at a compound annual growth rate of 7.57 percent through 2020, based on a ResearchMoz report. A boost in spinal disorder cases will spur market growth, along with an increase in industry adoption of the MI sacroiliac joint fusion technique.
The stem cell procedure that may change the sports medicine field in 2017
Physicians, healthcare professionals and members of the MLB community will keep a close eye on Red Sox pitcher Drew Pomeranz's recovery from a potentially career-saving stem cell procedure, according to The Boston Globe. Steve Yoon, MD, of the Los Angeles-based Kerlan-Jobe Orthopaedic Clinic extracted bone marrow from Mr. Pomeranz's hip bone and back and injected it into his flexor tendon. If Mr. Pomeranz has a successful 2017 season, the number of players undergoing stem cell procedures may rise.